Human Genome Research in Texas
Human Genome Research (93.172) awarded $101 million to recipients in Texas in 53 grants from fiscal 2021 to 2025, 4.7% of the program's national total. Baylor College of Medicine received the most, $62.9 million.
- Awarded in Texas$101 million
- Awards53
- Share of the program4.7%
- Rank among states6th of 45
- National total$2.2 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 26 | $20.4 million |
| FY 2022 | 19 | $16.5 million |
| FY 2023 | 25 | $21.2 million |
| FY 2024 | 25 | $21.3 million |
| FY 2025 | 27 | $22.0 million |
Recipients in Texas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Baylor College of Medicine | Colleges and universities | 24 | $62.9 million |
| The University of Texas Southwestern Medical Center | Colleges and universities | 4 | $10.2 million |
| University of Texas Health Science Center at Houston | Colleges and universities | 7 | $9.5 million |
| The University of Texas Rio Grande Valley | Colleges and universities | 1 | $6.6 million |
| Constantiam Biosciences Inc. | Small businesses | 2 | $2.5 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | State and local governments | 2 | $2.5 million |
| Geneial LLC | Small businesses | 2 | $2.4 million |
| Prairie View A&m University | Colleges and universities | 2 | $1.1 million |
| William Marsh Rice University | Colleges and universities | 2 | $1.0 million |
| Syntaxisbio Inc. | Small businesses | 2 | $785,364 |
Open opportunities under this program
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
See all 65 on the program page
Questions people ask
How much Human Genome Research money goes to Texas?
$101 million from fiscal 2021 to 2025, across 53 awards. Texas ranks 6th of 45 states and territories for this program.
Who receives Human Genome Research money in Texas?
The largest recipient is Baylor College of Medicine, with $62.9 million in 24 awards. Next are The University of Texas Southwestern Medical Center and University of Texas Health Science Center at Houston.
Can organizations in Texas apply now?
Yes, 65 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Human Genome Research in other states
Other large programs in Texas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Unaccompanied Alien Children Program
- Special Education Grants to States
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii